title: Thalidomide-induced hemorrhagic rash in a patient with myelofibrosis and delta-granule storage pool disease.
abstract: Thalidomide is one of the immunomodulating agents used in current oncology practice. We present a case of hemorrhagic rash induced by thalidomide in a patient with delta granule storage pool disease. The patient was getting thalidomide for underlying myelofibrosis.
authors.affiliation: University of Toledo Medical Center, Toledo, OH.
authors.forename: Asma
authors.initials: A
authors.lastname: Taj
authors.forename: Kamal
authors.initials: K
authors.lastname: Abbi
authors.forename: Roland T
authors.initials: RT
authors.lastname: Skeel
mesh_terms: D000368:Aged; D000417:Albinism / Q000473:pathology; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced* / Q000473:pathology; D006474:Hemorrhagic Disorders / Q000473:pathology; D022861:Hermanski-Pudlak Syndrome / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D017445:Skin Diseases, Vascular / Q000139:chemically induced / Q000473:pathology; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide